No retraction, correction or concern found when last checked on Oct 17, 2026.
Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis
Lukas Schwingshackl, Carolina Schwedhelm, Cecilia Galbete and 1 more
Nutrients · 2017 · Meta-analysis · CC BY
Abstract
The aim of the present systematic review and meta-analysis was to gain further insight into the effects of adherence to Mediterranean Diet (MedD) on risk of overall cancer mortality, risk of different types of cancer, and cancer mortality and recurrence risk in cancer survivors. Literature search was performed using the electronic databases PubMed, and Scopus until 25 August 2017. We included randomized trials (RCTs), cohort (for specific tumors only incidence cases were used) studies, and case-control studies. Study-specific risk ratios, hazard ratios, and odds ratios (RR/HR/OR) were pooled using a random effects model. Observational studies (cohort and case-control studies), and intervention trials were meta-analyzed separately. The updated review process showed 27 studies that were not included in the previous meta-analysis (total number of studies evaluated: 83 studies). An overall population of 2,130,753 subjects was included in the present update. The highest adherence score to a MedD was inversely associated with a lower risk of cancer mortality (RRcohort: 0.86, 95% CI 0.81 to 0.91, I2 = 82%; n = 14 studies), colorectal cancer (RRobservational: 0.82, 95% CI 0.75 to 0.88, I2 = 73%; n = 11 studies), breast cancer (RRRCT: 0.43, 95% CI 0.21 to 0.88, n = 1 study) (RRobservational: 0.92, 95% CI 0.87 to 0.96, I2 = 22%, n = 16 studies), gastric cancer (RRobservational: 0.72, 95% CI 0.60 to 0.86, I2 = 55%; n = 4 studies), liver cancer (RRobservational: 0.58, 95% CI 0.46 to 0.73, I2 = 0%; n = 2 studies), head and neck cancer (RRobservational: 0.49, 95% CI 0.37 to 0.66, I2 = 87%; n = 7 studies), and prostate cancer (RRobservational: 0.96, 95% CI 0.92 to 1.00, I2 = 0%; n = 6 studies). Among cancer survivors, the association between the adherence to the highest MedD category and risk of cancer mortality, and cancer recurrence was not statistically significant. Pooled analyses of individual components of the MedD revealed that the protective effects appear to be most attributable to fruits, vegetables, and whole grains. The updated meta-analysis confirms an important inverse association between adherence to a MedD and cancer mortality and risk of several cancer types, especially colorectal cancer. These observed beneficial effects are mainly driven by higher intakes of fruits, vegetables, and whole grains. Moreover, we were able to report for the first time a small decrease in breast cancer risk (6%) by pooling seven cohort studies.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.
1. Introduction
Mortality rate due to cancer has been decreasing since the 1990s, most likely due to improved measures of preventive examinations as well as therapeutic interventions. However, this heterogeneous complex of diseases still remains one of the major causes of premature death worldwide as it is ranked second to cardiovascular diseases in current statistics. Cancer incidence is estimated to be 18% by the year 2030.
Tumors are regarded to be an age-dependent phenomenon. Despite this, cancer and other chronic diseases increasingly manifest themselves at a younger age. This emphasizes the fact that the growing incidence of malignant diseases is not exclusively attributable to an increase in life expectancy, but rather due to a number of basic environmental and lifestyle risk factors. Approximately 5–10% of all tumor diseases are caused by genetic predisposition, while the pathogenesis of the remaining 90–95% can be explained by unfavorable environmental conditions or an unhealthy lifestyle. The latter can mainly be characterized by an unbalanced diet, lack of exercise, and consumption of alcohol and tobacco.
These are modifiable risk factors, meaning that the manifestation of many types of cancer can be prevented or at least postponed. The World Cancer Research Fund (WCRF) assumes that 3–4 million cases of cancer worldwide might be avoided by adopting a healthier lifestyle. The transition from a detrimental to a beneficial lifestyle cannot always be reduced to a simple formula, e.g., abstention in the case of tobacco consumption. It has been suggested that approximately 30% of cancers can be prevented by a healthy diet, however, foods simultaneously contain both ingredients that are protective and others that may cause harm. Some specific bioactive compounds from foods with tumor-preventive potential have been characterized in the past, e.g., polyphenols, n-3 fatty acids, or monounsaturated fatty acids. By contrast, alcohol or nitrosamines were identified as ingredients correlated with an increased risk of cancer. Another very important aspect in this regard is the growing number of cancer survivors. Since its first mention by Fitzhugh Mullan in 1985, this term has not been given a distinct definition. However, it is generally acknowledged to include patients with diagnosed cancer who have carried out all required therapeutic measures and are currently showing no symptoms of disease (in remission). This group of the population still has to cope with side-effects of their specific therapy as well as the threat of recurrence. Due to heightened awareness of the necessity of check-ups and routine examinations as well as evolved diagnostic and therapeutic tools, it is reasonable to speculate that the number of cancer survivors will increase substantially in the years ahead.
Dietary interventions will represent an effective measure in secondary/tertiary prevention or as a part of an adjunctive therapy. Despite this, there are at present very few evidence-based nutritional recommendations for cancer survivors.
Rather than focusing on single nutrients, the assessment of dietary patterns might be a more adequate approach to clarify the connections between nutrition and cancer. In contrast to associations based on single-nutrient analyses, dietary patterns allow for a simultaneous assessment of favorable and unfavorable components in food as well as their interdependencies. The Mediterranean diet (MedD) belongs to the a priori defined dietary patterns. For this type of pattern, adherence to a regimen settled in advance has been extensively assessed and consecutively associated with health parameters. The term MedD was coined by Keys and co-workers after observing significantly lower rates of coronary heart disease in countries bordering the Mediterranean Sea (Cyprus, Greece, and Italy) as compared to The Netherlands, USA, or Finland.
A MedD is characterized by a high consumption of plant-based foods, especially whole grain products, vegetables, fruits, nuts, and legumes with regular intake of fish and seafood. Eggs, red and processed meat as well as high-fat dairy products are consumed in low amounts. Additional indicators often used to describe a MedD are moderate alcohol consumption, preferably red wine taken with meals. Fat is predominately provided in the form of olive oil. Taken together, this results in a dietary pattern with a low content of saturated fatty acids (7–8% of daily total energy consumption) and a total percentage of fat of 30–40% per day.
Despite the limitations regarding the exact recording of the adherence to a MedD and the small number of studies investigating corresponding pathogenetic mechanisms, systematic reviews and meta-analyses of observational studies provide evidence that a MedD exerts protective functions with respect to tumor incidence and mortality. In a clinical trial, choice of diet orientated towards a Mediterranean pattern was found to be associated with reduced all-cause mortality as well as a 61%-decrease in cancer incidence. In addition, a primary-preventive effect of a MedD supplemented with extra-virgin olive oil on breast cancer was reported.
We decided to update our previous meta-analyses on the topic of MedD and cancer for the second time due to the following reasons: a number of additional epidemiological studies and randomized controlled trials (RCTs) investigating the correlations between MedD and risk of cancer have meanwhile been published and will therefore allow for a more comprehensive synthesis of the corresponding data; the same applies for studies investigating the effects of MedD in cancer survivors (where the previous analysis did not yield any significant correlation between adherence to MedD and cancer mortality or recurrence); new types of cancer localizations have been taken into consideration. In addition, to gain further insights into the complex relationship between diet and cancer, we analyzed the effects of specific food groups typical of the MedD on tumor incidences in this update.
2. Methods
The review protocol of the previous versions of the systematic review is registered in PROSPERO International Prospective Register of Systematic Reviews (https://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42013004382).
2.1. Data Sources and Searches
A literature search was performed using the electronic databases PubMed (25 August 2017), and Scopus (25 August 2017) using the following search terms for PubMed (Appendix A).
The search strategy had no language restrictions. Moreover, reference lists from reviews, meta-analyses, and the retrieved articles were searched to identify further relevant studies. Literature search was conducted by one author (LS), with questions or uncertainties resolved by discussion with another author (GH).
2.2. Study Selection
Cohort studies and case-control studies investigating the association between the MedD and risk of cancer mortality and cancer types in the general population; cancer mortality and cancer recurrence among cancer survivors were included in this update.
2.3. Data Extraction
The following data were extracted from each study as reported in the previous version: name of first author, country, study name, study design, outcome, population size, follow-up, age at entry, sex, components of score, score range, adjustment factors, and risk estimates (most adjusted Hazard ratio (HR), Risk ratio (RR) or Odds ratio (OR) comparing highest vs. lowest adherence category) with their corresponding 95% CIs.
2.4. Definition: Adherence to Mediterranean Diet
The two intervention trials differed regarding food components in the MedD intervention groups. Whereas higher intakes of plant based foods such as vegetables, fruits, nuts and legumes were recommended in the PREDIMED as well as the Lyon Diet Heart study, the recommended fat source in the PREDIMED study was extra virgin olive oil and nuts, whereas in the intervention group in the Lyon Heart Study was supplemented with rapeseed oil margarine.
For observational studies meta-analysis, the lowest adherence to MedD category was compared with the highest MedD category (according to the MedD scores by Trichopoulou, Fung, or Panagiotakos; with the exception of six studies that used factor analysis or principal component analysis to define the MedD (authors named these MedD pattern): Menotti et al. (2011) (HR: per 1 standard deviation increase), Murtaugh et al. (2008) (OR: fourth vs. first quartile), Cottet et al. (2005) (OR: third vs. first tertile), Bessaoud et al. (2012) (OR per increment of one standard error), Castello et al. (2017a) (OR: fourth vs. first quartile), and Castello et al. (2017b) (OR: fourth vs. first quartile). The maximum ranges of the different MedD scores are reported in Table 1.
2.5. Statistical Analysis
The meta-analysis was performed by combining the multivariable adjusted RRs, HR or ORs of the highest compared with the lowest MedD adherence category based on random effects model using the DerSimonian-Laird method, which incorporated both within and between study variability. Because outcomes were not very rare and heterogeneity modeling was deemed important, the random effects model was used.
A second meta-analysis was performed to compare the effects of the different dietary components of the Mediterranean dietary pattern on overall cancer risk, based on data given within the papers included in the present meta-analysis. To evaluate the weighting of each study, the standard error for the logarithm HR/RR/OR of each study was calculated and regarded as the estimated variance of the logarithm HR/RR/OR, using an inverse variance method. For the high vs. low adherence to MedD adherence category studies were grouped according to the different clinical outcomes (overall risk of cancer mortality, and risk of colorectal cancer/breast cancer/prostate cancer/gastric cancer/head and neck cancer/esophageal cancer/pancreatic cancer/liver cancer/ovarian cancer/endometrial cancer/respiratory cancer/bladder cancer/gallbladder cancer/biliary tract cancer/and lymphoma). Observational studies (cohort and case-control studies), and intervention trials were meta-analyzed separately. Meta-analysis was stratified for observational studies by study design: cohort studies, and case-control studies.
Heterogeneity was estimated by the Cochrane Q test together with the I2 statistic. An I2 value >50% indicates substantial heterogeneity across studies. Potential small-study effects, such as publication bias, were explored using Egger’s test and funnel plots when at least 10 studies were available, as recommended by the Cochrane Handbook. All analyses were conducted using the Review Manager by the Cochrane Collaboration (version 5.3 Copenhagen: The Nordic Cochrane Centre) and Stata 12.0 (Stata-Corp, College Station, TX, USA).
3.1. Literature Search and Study Characteristics
The detailed steps of the updated meta-analysis article search (Supplementary Materials Figure S1) and selection process are given as an adapted Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Taken together, 83 studies were included in the present systematic review update (27 additional studies (two randomized trials, 16 cohort studies, and nine case-control studies) were identified that were not included in the previous meta-analyses).
General characteristics of these additional studies are summarized in Table 1. For the present updated meta-analyses, data of new studies were synthesized together with the data of the previous reports. Overall, two RCTs, including 4887 subjects; 51 cohort studies including 2,025,303 subjects (incidence cases; biliary tract: 163; bladder: 1804; breast: 18,782; colorectal: 15,108; endometrial: 1392; esophageal: 848; gallbladder: 77; gastric: 1382; head and neck: 1868; liver: 509; pancreatic: 865; prostate: 29,806; ovarian: 696; respiratory: 9875); and 30 case-control studies with 100,563 subjects met the objectives and were included in the updated meta-analysis. An overall population of 2,130,753 subjects was included in the present update.
3.2. Main Outcomes
Documentations of the different clinical outcomes are distributed as follows: overall risk of cancer mortality was evaluated in 14 cohorts and one RCT; breast cancer risk in one RCT, seven cohorts and nine case-control studies; colorectal cancer risk in six cohorts and five case control studies; prostate cancer risk in three cohorts and three case-control studies; gastric cancer risk in two cohorts and two case-control study; head and neck cancer in one RCT, in one cohort study and six case-control studies; endometrial cancer in one cohort and two case-control studies; respiratory cancer in one RCT, and three cohort studies; bladder cancer in two cohort studies; liver cancer, pancreatic cancer and esophageal cancer in one cohort study and one case-control study; ovarian, gallbladder, and biliary tract cancer in one cohort study each; lymphoma in one case control study; cancer mortality among cancer survivors in four cohort studies; cancer recurrence among cancer survivors in one cohort study; and cancer-specific mortality in one cohort study.
Using a random effects model, we found that the highest adherence score to the MedD was inversely associated with a lower risk of overall cancer mortality (RRcohort: 0.86, 95% confidence interval (CI) 0.81 to 0.91; I2 = 81%; n = 15 studies) but not among one RCT (RRRCT: 0.75, 95% CI 0.17 to 3.33, I2 = NA) (Supplementary Materials Figure S2, Table S2). Among cancer survivors, we observed no association between the adherence to the highest MedD category and risk of cancer mortality (RR: 0.95, 95% CI 0.82 to 1.12; I2 = 5%; n = 4 studies) (Supplementary Materials Figure S3). Moreover, high adherence to a Mediterranean dietary pattern was inversely associated with risk of colorectal cancer (RRobservational: 0.82, 95% CI 0.75 to 0.88; I2 = 73%, n = 11 studies; RRcohort: 0.86, 95% CI 0.80 to 0.92, I2 = 28%, n = 6 studies; RRcase-control: 0.71, 95% CI 0.57 to 0.88, I2 = 88%, n = 5 studies) (Supplementary Materials Figure S4) and breast cancer (RRRCT: 0.43, 95% CI 0.21 to 0.88, I2 = NA%, n = 1 study; RRobservational: 0.92, 95% CI 0.89 to 0.96, I2 = 8%, n = 16 studies; RRcohort: 0.94, 95% CI 0.90 to 0.99, I2 = 11%, n = 7 studies; RRcase-control: 0.89, 95% CI 0.85 to 0.94, I2 = 0%, n = 9 studies) (Supplementary Materials Figure S5). With respect to incidence of all other different types of cancer, results are summarized in Table 2 and the corresponding forest plots are given in Figures S2–S20.
3.3. Food Group Components of the MedD and Risk of Cancer
Pooled estimates for the single components of the Mediterranean dietary pattern shown in Figure 1 revealed an inverse association for fruit consumption (RR: 0.93, 95% CI 0.89 to 0.97, I2 = 60%, n = 13 studies), vegetable intake (RR: 0.96, 95% CI 0.93 to 0.98, I2 = 0%, n = 14 studies), whole grain intake (RR: 0.91, 95% CI 0.87 to 0.95, I2 = 31%, n = 9 studies), and moderate alcohol consumption (within the range) (RR: 0.89, 95% CI 0.85 to 0.93), compared to higher intakes and cancer risk. No significant associations were observed for intakes of cereals, dairy, fish, legumes, meat, nuts, or olive oil (Figure 1).
3.4. Publication Bias
The Egger’s linear regression tests provided no evidence for a publication bias for overall cancer mortality (p = 0.86), breast cancer (p = 0.39), and colorectal cancer (p = 0.14), following comparison of the highest vs. lowest adherence to MedD category (Supplementary Materials Figures S21–S23). Funnel plots were only generated when at least 10 studies were available for a comparison. The funnel plots for risk of overall cancer mortality as well as risk of breast and colorectal cancer indicate moderate asymmetry, suggesting that publication bias cannot be completely excluded as a factor of influence on the present meta-analysis (Supplementary Materials Figures S21–S23).
4. Discussion
Following the synthesis of data from RCTs as well as cohort and case-control studies in the present systematic review, strongest adherence to a MedD was inversely associated with cancer mortality and risk of colorectal, breast, gastric, liver, head and neck, gallbladder, and biliary tract cancer. No significant associations could be observed with respect to other types of cancer and for cancer survivors. Considering dietary patterns instead of single nutrients or foods appears to have advantages in every respect. Foods are not consumed in separation and their health-related effects are additive or even synergistic. Consequently, the Greek cohort of the EPIC study revealed that the inverse association between adherence to a MedD and cancer risk is not due to any single component of this diet but rather an effect of the complete pattern. Contradictory to these observations, we could show significant inverse correlations between specific food groups typical for a MedD pattern (i.e., alcohol in moderate amounts, fruits, vegetables, and whole grains) and overall cancer risk (see Figure 1). In addition, a trend for potentially beneficial effects was detected for dairy, fish, and nuts, while meat pointed towards deleterious mechanisms. Fruits and vegetables contain numerous components known to have favorable effects on inflammatory, cellular redox, as well as metabolic processes and endothelial function, which might add up to their tumor-protective impact. In addition, regular consumption of fruits and vegetables facilitates weight management in overweight subjects to counter obesity as a risk factor for cancer. Whole grain products contain phytic acid, resistant starch, and soluble fiber, which are able to bind and neutralize potentially carcinogenic compounds in food. An inverse association between whole grain intake and cancer risk was described in other meta-analyses as well. Dairy products are included in the MedD pattern as a detrimental component. However, evidence regarding their health effects, especially for cancer, is controversial. A recent meta-analysis suggested dairy products are associated with a reduced risk for colorectal cancer risk, whereas a higher risk of prostate cancer has been reported. Moreover, consumption of fermented dairy products was associated with a decreased risk to become obese or diabetic. The health-promoting effects of dairy products might be explained by their high content of calcium, vitamins, and protein. Inverse associations between fish intake and all-cause as well as cancer mortality could be observed in various meta-analyses. With respect to mechanisms, growth inhibitory, pro-apoptotic or anti-angiogenic effects can be attributed to the high amount of n-3 fatty acids present in fish. Tree nuts contain anti-inflammatory, anti-oxidative, and endothelium-protective substances such as fiber, mono- and polyunsaturated fatty acids, or secondary plant metabolites which might prevent tumor pathogenesis and progression. A significant cancer-protective effect of nuts could be demonstrated in a recent meta-analysis by Aune et al.. Unfavorable effects of (red) meat and processed meat products might be due to ingredients promoting pro-inflammatory and pro-oxidative metabolic processes, e.g., nitrosamines, iron, or saturated fatty acids. A positive association between consumption of red meat and all-cause mortality could be observed in prospective cohorts from Europe and the US.
A specific and controversial “ingredient” of a MedD is ethanol, usually represented in the form of red wine. In some of the assessment indices mentioned, the highest rating/level of adherence could only be achieved when alcohol is consumed on a daily basis in moderate amounts. Ethanol is considered as a carcinogen in humans by the Agency for Research on Cancer. The WCRF report summarizes alcoholic beverages as a risk factor in the development of different carcinomas (e.g., mouth, pharynx, larynx, esophagus, liver, colorectal, breast in pre- and post-menopause), with grades of evidence ranging between “convincing” and “probable”, respectively. In some studies, consumption of alcoholic beverages even in low to moderate amounts was associated with an increased risk of colorectal, liver, and breast cancer as well as carcinomas of the larynx, pharynx, and esophagus. Although red wine contains a number of potential protective ingredients such as anti-oxidative polyphenols, its beneficial role regarding malignant diseases is discussed controversially, e.g., with respect to non-Hodgkin’s lymphoma, renal cell carcinoma, breast cancer, or thyroid cancer. When assessing the effects of a MedD on health and disease, one should keep in mind that the different scores for this dietary pattern may include alcoholic beverages. However, adherence to a MedD is usually defined by categories classified according to pre-defined cut off points. Thus, individuals in the highest categories cannot be discriminated according to their consumption of alcoholic beverages. Therefore, at present, it seems to be impossible to make an unequivocal statement on the effects of alcohol consumption regarding tumor pathogenesis. It seems pointless to recommend moderate alcohol consumption to hitherto abstinent individuals, especially cancer survivors.
Taken together, these data provide evidence that the combination of food groups in order to compose a pattern corresponding to a MedD exerts benefits with respect to tumor pathogenesis. However, it remains difficult to define the MedD as a distinct pattern. According to Simopoulos, the term “Mediterranean diet” is even misleading, since there is no clear-cut definition of a MedD but rather a number of variations based on different cultural, religious, ethnical, and economical versions of this regimen practiced by the populations of countries bordering the Mediterranean Sea. Frequently used indices to assess the adherence to a MedD are the ones by Trichopoulou, the modified MedD index by the same group, the alternate Mediterranean Diet index, or the relative Mediterranean Diet index. The initial three indices chose gender-specific medians of intake of relevant food groups as cutoff-points. It seems obvious that cutoff-points defined by medians vary between different populations, leading to an almost indefinite number of MedD subtypes. As a result, it will become impossible to differentiate between preferable and dissenting intakes. Moreover, determination of the components of a MedD is inconsistent between different epidemiological studies. The characteristics of a MedD have changed considerably since the 1960s. Taking into account only some of its constituents does not justify categorization as a MedD pattern. Thus, assessing the components of a MedD with respect to their potential tumor-preventive properties is subject to a number of prior conditions. It has to be noted that a large number of studies enrolled in the present systematic review fulfill these requirements, such as the special consideration of whole-grain products in the cereals category or of extra virgin olive oil as the predominant provider of fat. On the other hand, the protective effects of olive oil are most likely due to its content of polyphenols as well as their interactions. Because of manufacturing conditions, not all of these compounds are present in every brand of olive oil, not even in extra virgin olive oil varieties. Additionally, most studies measured intake of alcoholic beverages without special consideration of red wine (exceptions, e.g.,). For future assessments of a MedD it might be helpful to use a literature-based score implementing portions of each food group to achieve a pre-defined score such as the one suggested by Sofi et al.. In addition, it might be helpful to explore linear trends via dose-response analyses as well as possible non-linear associations as has recently been done for the relation between 12 food groups and risk of type 2 diabetes mellitus.
Most of the data synthesized meta-analytically in the present systematic review were derived from epidemiological studies performed in either the US or European countries. These countries differ regarding their respective data on cancer prevalence, while at the same time, data from other countries are missing. Additional to differences in adherence to varying dietary patterns, country-specific data may be explained by genetic factors, geographic features, or mixed exposures to carcinogens. The different manifestation of harmful and beneficial determinants in single countries might contribute to both over- as well as underestimation of the effects of a MedD. In some studies, the inverse association between adherence to a MedD and risk of tobacco-related cancers was significantly more pronounced in the subgroup of active smokers.
The validity of our results is further limited by methodological shortcomings of some of the studies enrolled in the present systematic review. The most common tool to assess a dietary regimen in observational studies is the food frequency questionnaire. It is an established and cost-effective instrument, however, with a number of disadvantages. Lesser number of items and short survey periods might not necessarily represent a dietary pattern with impact on chronic diseases and mortality. However, most of the included studies did assess the whole diet via FFQ over a period of more than 12 months.
Another limitation was the lopsided availability of studies by type of cancer. The most frequently investigated tumor localizations in the present study were breast, colorectal, prostate, and head-and-neck cancer, while other types of cancer such as lung or esophageal cancer were explored to a lesser extent. Taken together, these limitations might at least in part explain the considerable heterogeneity present in our systematic review (Table 2).
The observed high statistical heterogeneity for cancer mortality was related to the different definitions for MedD pattern. Additional analyses indicated lower levels of heterogeneity when studies were grouped according to similar definitions of a MedD pattern (e.g., alternate MedD, or traditional MedD). The high levels of heterogeneity observed for colorectal cancer risk in the main analysis could not be confirmed for cohort studies in the stratified analysis, and were mainly driven by one large case-control study.
Due to the low number of studies available for several cancer types, we were not able to investigate properly potential sources of heterogeneity. However, statistical heterogeneity might be related to differences in adjustment factors, as well as heterogeneous definition of the MedD.
To some degree, our results might depend on residual confounders. Hypothesis-Driven dietary patterns represent one aspect of a multidimensional lifestyle complex including other factors such as exercise, smoking behavior, and alcohol consumption. Although the results of the studies are most often adjusted for these factors via multivariate analyses, we cannot exclude potential confounders as another limitation affecting our results. The benefits of a MedD were found to be depending on cohort characteristics such as smoking behavior, age groups, hormonal status, or gender.
Strengths of the present study are the extensive literature research with strict adherence to quality standards set by PRISMA guidelines. Data were synthesized predominantly from observational studies enrolling a high number of participants, which, in some cases, may compensate for the low number of studies investigating specific tumor localizations.
5. Conclusions
In conclusion, the present update of our systematic review and meta-analyses provided additional important evidence for a beneficial effect of high adherence to MedD with respect to primary prevention overall cancer risk and specific types of cancer, especially colorectal cancer. These observed beneficial effects are mainly driven by higher intakes of fruits, vegetables, and whole grains. Moreover, we report for the first time a small decrease in breast cancer risk (6%) with the pooling seven cohort studies. To further elucidate the relationship between Mediterranean dietary patterns and cancer types, future studies should adopt a precise definition of a MedD.
References 162
- 1.
Stewart B.W., Bray F., Forman D., Ohgaki H., Straif K., Ullrich A., Wild C.P. Cancer prevention as part of precision medicine: ‘Plenty to be done’. Carcinogenesis. 2016;37:2-9.
Not in our library10.1093/carcin/bgv166
- 2.
Tyrovolas S., Panagiotakos D.B. The role of Mediterranean type of diet on the development of cancer and cardiovascular disease, in the elderly: A systematic review. Maturitas. 2010;65:122-130.
Not in our library10.1016/j.maturitas.2009.07.003
- 3.
Kurtz Z., Peckham C.S., Ades A.E. Changing prevalence of juvenile-onset diabetes mellitus. Lancet. 1988;2:88-90.
Not in our library10.1016/s0140-6736(88)90015-3
- 4.
Ligibel J.A., Alfano C.M., Courneya K.S., Demark-Wahnefried W., Burger R.A., Chlebowski R.T., Fabian C.J., Gucalp A., Hershman D.L., Hudson M.M., et al. American Society of Clinical Oncology position statement on obesity and cancer. J. Clin. Oncol. 2014;32:3568-3574.
Not in our library10.1200/jco.2014.58.4680
- 5.
Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., Sung B., Aggarwal B.B. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008;25:2097-2116.
Not in our library10.1007/s11095-008-9661-9
- 6.
WCRF. World Cancer Research Fund International. Continuous Update Project (Cup). 2017.
Not in our library
- 7.
Heller M.C., Keoleian G.A., Willett W.C. Toward a life cycle-based, diet-level framework for food environmental impact and nutritional quality assessment: A critical review. Environ. Sci. Technol. 2013;47:12632-12647.
Not in our library10.1021/es4025113
- 8.
Milner J.A. Molecular targets for bioactive food components. J. Nutr. 2004;134:2492s-2498s.
Not in our library10.1093/jn/134.9.2492s
- 9.
Bouvard V., Loomis D., Guyton K.Z., Grosse Y., Ghissassi F.E., Benbrahim-Tallaa L., Guha N., Mattock H., Straif K., International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16:1599-1600.
Not in our library10.1016/s1470-2045(15)00444-1
- 10.
Bagnardi V., Rota M., Botteri E., Tramacere I., Islami F., Fedirko V., Scotti L., Jenab M., Turati F., Pasquali E., et al. Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. Br. J. Cancer. 2015;112:580-593.
Not in our library10.1038/bjc.2014.579
- 11.
Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Proc. Nutr. Soc. 2008;67:253-256.
Not in our library10.1017/s002966510800712x
- 12.
Mullan F. Seasons of survival: Reflections of a physician with cancer. N. Engl. J. Med. 1985;313:270-273.
Not in our library10.1056/nejm198507253130421
- 13.
DeSantis C.E., Lin C.C., Mariotto A.B., Siegel R.L., Stein K.D., Kramer J.L., Alteri R., Robbins A.S., Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin. 2014;64:252-271.
Not in our library10.3322/caac.21235
- 14.
Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011;61:69-90.
Not in our library10.3322/caac.20107
- 15.
Rowland J.H., Kent E.E., Forsythe L.P., Loge J.H., Hjorth L., Glaser A., Mattioli V., Fossa S.D. Cancer survivorship research in Europe and the United states: Where have we been, where are we going, and what can we learn from each other? Cancer. 2013;119(Suppl. 11):2094-2108.
Not in our library10.1002/cncr.28060
- 16.
Schwedhelm C., Boeing H., Hoffmann G., Aleksandrova K., Schwingshackl L. Effect of diet on mortality and cancer recurrence among cancer survivors: A systematic review and meta-analysis of cohort studies. Nutr. Rev. 2016;74:737-748.
Not in our library10.1093/nutrit/nuw045
- 17.
Collins C.E., Young A.F., Hodge A. Diet quality is associated with higher nutrient intake and self-rated health in mid-aged women. J. Am. Coll. Nutr. 2008;27:146-157.
Not in our library10.1080/07315724.2008.10719686
- 18.
Jacobs D.R., Gross M.D., Tapsell L.C. Food synergy: An operational concept for understanding nutrition. Am. J. Clin. Nutr. 2009;89:1543S-1548S.
Not in our library10.3945/ajcn.2009.26736b
- 19.
Edefonti V., Randi G., La Vecchia C., Ferraroni M., Decarli A. Dietary patterns and breast cancer: A review with focus on methodological issues. Nutr. Rev. 2009;67:297-314.
Not in our library10.1111/j.1753-4887.2009.00203.x
- 20.
Keys A. Mediterranean diet and public health: Personal reflections. Am. J. Clin. Nutr. 1995;61:1321S-1323S.
Not in our library10.1093/ajcn/61.6.1321s
- 21.
Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., Djordjevic B.S., Dontas A.S., Fidanza F., Keys M.H. The diet and 15-year death rate in the Seven countries study. Am. J. Epidemiol. 1986;124:903-915.
Not in our library10.1093/oxfordjournals.aje.a114480
- 22.
Schwingshackl L., Missbach B., Konig J., Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: A systematic review and meta-analysis. Public Health Nutr. 2015;18:1292-1299.
Not in our library10.1017/s1368980014001542
- 23.
Schwingshackl L., Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: A systematic review and meta-analysis of intervention trials. Nutr. Metab. Cardiovasc. Dis. 2014;24:929-939.
Not in our library10.1016/j.numecd.2014.03.003
- 24.
Fidanza F., Alberti A., Fruttini D. The Nicotera diet: The reference Italian Mediterranean diet. World Rev. Nutr. Diet. 2005;95:115-121.
Not in our library10.1159/000088278
- 25.
Fidanza F., Alberti A., Lanti M., Menotti A. Mediterranean Adequacy Index: Correlation with 25-year mortality from coronary heart disease in the Seven countries study. Nutr. Metab. Cardiovasc. Dis. 2004;14:254-258.
Not in our library10.1016/s0939-4753(04)80052-8
- 26.
- 27.
Willett W.C., Sacks F., Trichopoulou A., Drescher G., Ferro-Luzzi A., Helsing E., Trichopoulos D. Mediterranean diet pyramid: A cultural model for healthy eating. Am. J. Clin. Nutr. 1995;61:1402S-1406S.
Not in our library10.1093/ajcn/61.6.1402s
- 28.
Schwingshackl L., Hoffmann G. Adherence to Mediterranean diet and risk of cancer: A systematic review and meta-analysis of observational studies. Int. J. Cancer. 2014;135:1884-1897.
Not in our library10.1002/ijc.28824
- 29.
- 30.
Sofi F., Macchi C., Abbate R., Gensini G.F., Casini A. Mediterranean diet and health status: An updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17:2769-2782.
Not in our library10.1017/s1368980013003169
- 31.
Schwingshackl L., Hoffmann G. Does a Mediterranean-type diet reduce cancer risk? Curr. Nutr. Rep. 2016;5:9-17.
Not in our library10.1007/s13668-015-0141-7
- 32.
De Lorgeril M., Salen P., Martin J.L., Monjaud I., Boucher P., Mamelle N. Mediterranean dietary pattern in a randomized trial: Prolonged survival and possible reduced cancer rate. Arch. Intern. Med. 1998;158:1181-1187.
Not in our library10.1001/archinte.158.11.1181
- 33.
Toledo E., Salas-Salvado J., Donat-Vargas C., Buil-Cosiales P., Estruch R., Ros E., Corella D., Fito M., Hu F.B., Aros F., et al. Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: A randomized clinical trial. JAMA Intern. Med. 2015;175:1752-1760.
Not in our library10.1001/jamainternmed.2015.4838
- 34.
Estruch R., Ros E., Salas-Salvado J. Primary prevention of cardiovascular disease with a mediterranean diet. N. Engl. J. Med. 2013;368:1279-1290.
Not in our library10.1056/nejmoa1200303
- 35.
De Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., Guidollet J., Touboul P., Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-1459.
Not in our library10.1016/s0140-6736(94)92580-1
- 36.
Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003;348:2599-2608.
Not in our library10.1056/nejmoa025039
- 37.
Fung T.T., Hu F.B., McCullough M.L., Newby P.K., Willett W.C., Holmes M.D. Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J. Nutr. 2006;136:466-472.
Not in our library10.1093/jn/136.2.466
- 38.
Panagiotakos D.B., Pitsavos C., Arvaniti F., Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietscore. Prev. Med. 2007;44:335-340.
Not in our library10.1016/j.ypmed.2006.12.009
- 39.
Menotti A., Alberti-Fidanza A., Fidanza F., Lanti M., Fruttini D. Factor analysis in the identification of dietary patterns and their predictive role in morbid and fatal events. Public Health Nutr. 2012;15:1232-1239.
Not in our library10.1017/s1368980011003235
- 40.
Murtaugh M.A., Sweeney C., Giuliano A.R., Herrick J.S., Hines L., Byers T., Baumgartner K.B., Slattery M.L. Diet patterns and breast cancer risk in hispanic and non-Hispanic white women: The Four-Corners Breast Cancer Study. Am. J. Clin. Nutr. 2008;87:978-984.
Not in our library10.1093/ajcn/87.4.978
Cited by papers we hold 22
- Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer · 2024No notice
- The Mediterranean Diet: An Update of the Clinical Trials · 2022No notice
- Mediterranean Diet and Obesity-related Disorders: What is the Evidence? · 2022No notice
- Dietary patterns, caloric restrictions for management of cardiovascular disease and cancer; a brief review · 2022Not checked
- Tomatoes: An Extensive Review of the Associated Health Impacts of Tomatoes and Factors That Can Affect Their Cultivation · 2022No notice
- Association between overall diet quality and postmenopausal breast cancer risk in five Finnish cohort studies · 2021Not checked
- Oleuropein alleviates gestational diabetes mellitus by activating AMPK signaling · 2021Not checked
- Role of Diet in Colorectal Cancer Incidence · 2021No notice
- Bioactive Compounds and Quality of Extra Virgin Olive Oil · 2020No notice
- An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer · 2020No notice
- Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies · 2020No notice
- Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer · 2020No notice
- The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults · 2020No notice
- Defining a Healthy Diet: Evidence for the Role of Contemporary Dietary Patterns in Health and Disease · 2020No notice
- Wie hoch ist das Krebs-Risiko bei moderate Weinkonsum im Rahmen einer mediterranen Ernährung? · 2019Not checked
- Gut microbiome-Mediterranean diet interactions in improving host health · 2019No notice
- The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription · 2019No notice
- Dietary Patterns, Skeletal Muscle Health, and Sarcopenia in Older Adults · 2019No notice
- Virgin Olive Oil and Health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018 · 2019No notice
- Gut Microbiome: Profound Implications for Diet and Disease · 2019No notice
and 2 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.